AI can reduce R&D costs to alleviate looming patent cliff pressures
Speaking at CDMI Europe 2025, GlobalData pharma analyst George El-Helou says the use of AI in R&D could help mitigate patent cliff issues.
AI in Healthcare
Cognivia’s AI software predicts probability of trial patient dropping out
Using AI to forge the future of rare disease clinical trials
AI to become as foundational as the internet in clinical trials, experts say
CTSWC25: The future of clinical trial supply hinges on risk management
AI could personalise clinical trial consent, but privacy concerns remain
Pharma’s AI prospects get nudged into the future with EU’s AI act
Can AI replace medical writers? Experts say not immediately
